| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |